This report is an updated edition of a first study on cell technology, cell therapy, tissue engineering and gene therapy in Japan published in 2015. It aims to summarise key events which have taken place in academic and medical research in these different fields. Furthermore, the report includes information concerning Japanese industrial landscapes as well as Japanese Government activities related to these medical advances. Lastly, it provides various recommendations to EU companies for a successful market entry.
About the Expert:
Rolf Schmid is Founder and Director of Bio4Business, a consulting company in Stuttgart. Throughout his career, Mr Schmid was involved in activities and projects in Japan and since 2009 he is Coordinator for the Bilateral Cooperations of the State of Baden-Wurttemberg in the Field of Biotechnology with the State's Asian partners in China and Japan. Click here to access his profile page.
The recording of the past webinar covering this topic is available for online viewers here. (Once you are logged in, look for the link below the "After event information")
Picture copyright: From public domain.
Japan’s medical device market is highly dependent on imports, especially sophisticated products such as pacemakers and surgical robotic systems.
This website and related activities are managed by the EU-Japan Centre for Industrial Cooperation, a joint venture between the European Commission's Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs (DG GROW) and the Japanese Government's Ministry of Economy, Trade & Industry (METI).
This support is available for EU companies only. Please note that the validation process may take up to a couple of days and will be confirmed to you by email.
Hundreds of web pages with up-to-date information on Japan, more than 400 market reports and recorded webinars available as well as a lot of detailed information on Japanese business culture.